Amneal Pharmaceuticals
AMRX
$6.05
Share price
12.04%
Change (1 day)
245.71%
Change (1 year)
Categories
Earnings for Amneal Pharmaceuticals (AMRX)
Earnings in 2023 (TTM): -$40.27 M
According to Amneal Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$40.27 M. In 2022 the company made an earning of -$0.25 B a decrease over its 2021 earnings that were of $31.36 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Amneal Pharmaceuticals from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$40.27 M | -83.77% |
| 2022 | -$0.25 B | -891.07% |
| 2021 | $31.36 M | -187.66% |
| 2020 | -$35.78 M | -83.75% |
| 2019 | -$0.23 B | 8.64% |
| 2018 | -$0.21 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | 357.71% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -52.95% | 🇺🇸 USA |